| Multiple Chemical Sensitivities (MCS) |
| As a holistic practice, we strive to accommodate to our patients' sensitivities. Dr. Stagg uses several testing labs including Clifford Consulting and Research Lab who specializes in dental care and Doctor's Data Inc. who specializes in toxic elemental testing of multiple human tissues. Please follow the links to learn more about the tests and what each lab has to offer. The Clifford Materials Reactivity Testing (CMRT) screening process assists in identifying existing sensitivity problems in various chemical groups and families of compounds for our patients. The Doctor's Data Inc. analysis assess and detects heavy metal burden, nutritional deficiencies, gastrointestinal function, hepatic detoxification, metabolic abnormalities, and diseases of environmental origin. |
| Doctor's Data Inc. |
| Doctor's Data Inc. (DDI) testing provides a reliable analysis which are designed to detect our patient's sensitivities in order to provide Dr. Stagg with extensive information about their individual sensitivities. This will allow Dr. Stagg to utilize the least offensive materials during your treatment or Dr. Stagg may be also able to offer supplemental advice to make up for an nutritional deficiencies. See the lab's in depth analysis - Sample Report. You can find more information on the Doctor's Data Inc. website at www.DoctorsData.com |
| The Clifford Materials Reactivity Testing |
| The Clifford Materials Reactivity Testing (CMRT) screening process identifies existing sensitivity problems in various chemical groups and families of compounds for our patients. According to the lab, it includes over 12,600 trade-named dental products and 94 chemical groups and families. An orthopedic report is also included which accounts for 4,200 trade-named products for surgical applications. The report is designed to provide Dr. Stagg with extensive information about our patient’s individual dental sensitivities so that the least offensive materials can be chosen and used in their treatments You can find more information about the Sensitivity Test at www.CCRLab.com |
| What is Clifford Materials Reactivity Testing? Clifford Materials Reactivity Testing (CMRT) is a laboratory screening process used to help identify existing sensitivity problems to various chemical groups and families of compounds in an individual patient. This process is currently being implemented in the CMRT Dental Test. After a patient's test has been completed, the patient's reactivity test results are compiled in a report. We are currently reporting on over 15101 trade-named dental products and 96 chemical groups and families. We have also added a Orthopedic panel reporting on over 4700trade-named products for surgical applications. In modern society we come in contact with many substances every day in the food we eat, the products we use and the treatments we receive. Because each of us possesses a unique biochemistry, these substances effect each of us differently and in varying degrees. For some, the effects of certain substances (and their corrosion byproducts) can be toxic and hazardous, and may result in serious health problems. A substance which causes little or no reaction in one individual can prove harmful to another. Since these effects may vary in each of us, it is vital that these factors be considered when choosing dental and other materials for use in the body, especially in patients with special or unique health concerns. Clifford Materials Reactivity Testing (CMRT) provides dentists and physicians with extensive information about their patient’s individual sensitivities so that least offensive materials can be chosen and used in their treatments CMRT is not merely based upon the body's response to biomaterials themselves, but also upon response to corrosion byproducts of those materials. These byproducts are generated at various rates as the materials decompose or break down in the body. It is these products of decomposition that the body must deal with and which are most likely to cause untoward health effects and toxic conditions. The body produces systemic antibodies against challenging antigens and will maintain an immunologic record of the components or chemical families which have proven offensive and which can be observed by CMRT. |
| How does CMRT work? CMRT focuses on the premise that most harmful pharmacological or toxic encounters in the body will also form a parallel immune system challenge. The immune system recognizes the presence of a foreign substance, identifies its nature and then mounts a defensive action against it. Part of that defensive action is the production of specific antibodies which contribute to neutralizing the targeted foreign substance, destroying or altering its structure and binding the substance preparatory to its removal from the encounter site and elimination from the system. Even after the offending foreign substance can no longer be detected in body fluids and tissues, the specific antibodies against it remain present in the plasma/serum of the blood for a period of months to years. Additional quantities of the specific antibody can be quickly produced in the future if needed due to certain memory lymphocytic cells which have a long-term, enduring record of the antibody which counters the foreign substance. These memory cells will facilitate a quick response with replenishment of antibodies in the blood as needed. Sadly, the immune system is not especially effective in protecting the patient when it comes to the foreign substances such as those associated with restorative and reconstructive bio-materials. However, the requisite antibody response still takes place and the antibodies remain for extended periods of time. Detecting those antibodies at or above a relevant clinical threshold level is a useful indicator that the patient has experienced an adverse encounter with the offending substance and has developed a systemic sensitivity to it. CMRT looks for the presence of antibodies in patient serum at or above a relevant threshold which have been formed against the chemical groups and families of compounds that can be released from restorative and reconstructive bio-materials. The contributing source which initiated the creation of the antibodies is somewhat immaterial. Whether the offending substance first came from prior placement of the substance as part of a medical or dental procedure, or whether it came from food, water or environmental contact sources, once the body becomes sensitized it will react with the substance from any future source. Thus, if the patient has become sensitized to the offending substance from any source whatsoever, the dentist or physician will want to avoid placing new bio-materials which can exacerbate that existing sensitivity. CMRT identifies the reactive chemical group or family, and then correlates that finding with our database of bio-materials by trade-name. At the same time, it also indicates all products in the database by trade-name which have not shown any contraindicating components. The healthcare professional can easily check available bio-materials and identify those to avoid for the patient. |
| About Clifford Consulting and Research Clifford Consulting and Research Inc. (CCR), headquartered in Colorado Springs, Colorado, was founded in 1988 after the invention and development of the Clifford Materials Reactivity Testing (CMRT) concept by Walter J. Clifford, who currently serves as president of CCR. Mr. Clifford's development of the CMRT resulted in a new and unprecedented application of a well-proven technology known as the precipitin testing method. The precipitin testing method was used at the birth of microbiology nearly 100 years ago in detecting specific kinds of bacteria, and is currently employed in many laboratory tests and research efforts worldwide. Since it's beginning, CCR has expanded the service and scope of CMRT from reporting on 1500 trade-named products and 67 chemical groups and families in its earliest reports to reporting on over 15101 trade-named products and 96 chemical groups and families today. CMRT continues to maintain strict standards and quality controls resulting in an ongoing accuracy rate of ≥ 95% with over 50,000 patients tested. CCR's unrelenting commitment to values such as service, integrity, and innovation in promoting quality care for patients through testing and research has resulted in 25 years of rapid growth as a unique provider in the industry. CCR now offers information, services and seminars to healthcare professionals throughout the United States, as well as international locations. |
| Who should consider testing? We have found that most people have come in contact with a sufficient variety of substances to form a mature bio-record by the age of puberty. Because their bio-records may not be fully mature, caution should be used when considering this kind of testing for children. |
| Things you should know before testing Clifford Materials Reactivity Testing is intended as a screen for safe and unsafe materials for use in patients and is in no way to be considered a means of specific diagnosis or prognosis of any disease or condition. We have found that most people have come in contact with a sufficient variety of substances to develop their bio-record by the age of puberty. Because their bio- records are not fully mature, caution should be used when considering this kind of testing for children. Patients with unusual environmental sensitivities may exhibit reactions which do not pass through immune mechanisms. Since antibodies, in these instances , are not produced, first level testing results can be affected and provocative second level testing should be considered. While Clifford Materials Reactivity Testing may be useful in detecting chemical groups and products which are safe biologically for a patient, it does not address issues of mechanical performance or electro-activity between materials. While many patients have received insurance or third party reimbursement, our services are not approved for Medicare, Medicaid, MediCal or CHAMPUS participation and we do not accept insurance assignment. Testing charges are ultimately the responsibility of the patient. |
| Other factors to consider Some patients may actually become immuno-tolerant of an antigen. With the passage of time, antibody levels can fall below detectable limits if there has been no recurrent exposure to the antigen. However, memory lymphocytes may continue to be resident which are capable of eliciting a massive response should new exposure to that antigen occur. Such condition may not be detected at the time of testing and could pose a problem later. The problem of immuno-tolerance or non-response is below 5% in general population longitudinal testing. Cross-reactivity Cross-reactivity may occur in testing when an antibody manufactured in response to one antigen cross-reacts with a different antigen. We believe that while this may occur as a false positive in testing, such cross-reactivity will also be possible in-vivo and is therefore a valid consideration for avoiding the use of materials in question. Adjuvant effects may occur with some constituents such as aluminum and mercury when chemical groups that the patient might normally handle well, react adversely due to amplification of their properties by the adjuvant. These reactivities often disappear over a period of months in longitudinal testing sequences when the adjuvants are removed from the body and lifestyle of the patient. This may become a factor for temporization of sensitive patients with benign temporary materials for a period of months prior to final placement of long-term materials. It is not unusual to see some reactivity levels drop below detection limits, and even for some allergies to abate completely with adjuvant removal. Future reactivity testing of this type cannot predict future reactivity for materials which do not presently react. We have found that most people have come in contact with a sufficient variety of materials and substances to form a mature bio-record by the age of puberty. New reactivities in adult patients do not seem to occur often. Pediatric patients are not nearly as stable nor biologicaly experienced as their immune records have not fully matured. Therefore, caution should be used in considering and ordering this kind of testing for children. Long-term application of immuno-suppressive therapies or steroids may interfere with antibody production generally. Patients on such therapies may not have adequate levels of antibody response to chemical groups to be reliably detected in testing. Nutritional supplements and antibiotics are not known to induce such problems. |
| Ordering Materials Reactivity testing? We encourage all patients to work with a qualified healthcare professional who is licensed to order blood testing. Healthcare professionals offer invaluable service in diagnosing and evaluating your condition. In several states and countries it is now permissible to self order testing. Our company policy is to allow patients to self order testing only through the betterlabtestsnow.com website. Please note this service is not available to New York, New Jersey, and Rhode Island State patients. We feel this is a quality solution to individuals wishing to self order testing as it is staffed by responsive and knowledgeable professionals. All other orders must be ordered by a healthcare professional such as a medical doctor, dentist or other health care provider licensed to order blood testing. Patients seeking testing need only to request of their local healthcare provider that it be ordered. Doctors, dentists and other professionals can obtain free information and supplies for testing on this website, or by calling Clifford Consulting and Research at 719-550-0008. |
| Need a additional copy of your test results? We hope that your results become a valuable aid in your healthcare management and care. Additional copies of your results may be obtained for up to 7 years from the time of testing. Because of patient privacy regulations in the United States of America we require a signed records request to produce either paper or electronic copies of your test results. This form can be downloaded here, or from our downloads page. Please fill out the form completely and fax, email or mail it to our office for prompt service. Our fax number is: 719.550.0009 Our mailing address is: Clifford Consulting & Research, Inc. 4775 Centennial Blvd. #112 Colorado Springs, CO 80919 USA Our Email address: wjclifford@ccrlab.com |
| Each of us possesses a unique biochemistry, these substances effect each of us differently and in varying degrees. For some, the effects of certain substances (and their corrosion byproducts) can be toxic and hazardous, and may result in serious health problems. A substance which causes little or no reaction in one individual can prove harmful to another. Since these effects may vary in each of us, it is vital that these factors be considered when choosing dental and other materials for use in the body, especially in patients with special or unique health concerns. CMRT is not merely based upon the body's response to biomaterials themselves, but also upon response to corrosion byproducts of those materials. These byproducts are generated at various rates as the materials decompose or break down in the body. It is these products of decomposition that the body must deal with and which are most likely to cause untoward health effects and toxic conditions. The body produces systemic antibodies against challenging antigens and will maintain an immunologic record of the components or chemical families which have proven offensive and which can be observed by CMRT. |
     2120 Highway A1A Indian Harbour Beach, FL 32937 View Map || Phone: 321.777.2797 |
| Terms of Service || Copyright © 2015-2021 |
Copyright © 2024. All Rights Reserved. Website Powered By: JuneSites.com